GPC
35
6
NUE
41
2
FFIV
67
3
ZION
52
3
STT
64
5
GOOGL
66
2
JNJ
39
4
HCA
39
2
QRVO
20
2
SYF
83
7
SNA
58
2
AMZN
63
5
KEY
27
3
AZO
50
2
WAT
59
4
DGX
29
2
GWW
51
3
CSX
43
3
IVZ
48
3
MMM
37
2
GPC
35
6
NUE
41
2
FFIV
67
3
ZION
52
3
STT
64
5
GOOGL
66
2
JNJ
39
4
HCA
39
2
QRVO
20
2
SYF
83
7
SNA
58
2
AMZN
63
5
KEY
27
3
AZO
50
2
WAT
59
4
DGX
29
2
GWW
51
3
CSX
43
3
IVZ
48
3
MMM
37
2
Financhill
Back

Checkpoint Therapeutics 10K Form

Sell
49

CKPT
Checkpoint Therapeutics

Last Price:
$3.63
Seasonality Move:
-0.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CKPT News And Ratings

See the #1 stock for the next 7 days that we like better than CKPT

CKPT Financial Statistics

Sales & Book Value

Annual Sales: $103K
Cash Flow: $-11.2M
Price / Cash Flow: 0
Annual Sales: $-0.27
Price / Book: 0

Profitability

EPS (TTM): -1.84000
Net Income (TTM): $-46.5M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -632.35%

Checkpoint Therapeutics Earnings Forecast

Key Checkpoint Therapeutics Financial Ratios

  • The Research & Development expenses have been 42,297.09% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CKPT is -50,336.89% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Checkpoint Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CKPT
CUSIP: 162828
Website: checkpointtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.26
Quick Ratio: 0.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CKPT Technical Analysis vs Fundamental Analysis

Sell
49
Checkpoint Therapeutics (CKPT) is a Sell

Is Checkpoint Therapeutics a Buy or a Sell?